“The only thing that matters is profit, ... This drop in the Nasdaq is long overdue. The real question is not why it's dropping but why it got so high.”
“This is disappointing news for patients and for us at Bayer. We had hoped that this agent would be a significant advance in the treatment of these diseases.”
